BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Illumina, Inc. 

9885 Towne Centre Drive

San Diego  California  92121-1975  U.S.A.
Phone: 858-202-4500 Fax: 858-202-4545


SEARCH JOBS


innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Leading-edge products and services
Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine. Our offering includes leading-edge solutions for:

  • SNP genotyping
  • Copy number variation
  • DNA methylation studies
  • Gene expression profiling
  • Low-multiplex analysis of DNA, RNA, and protein

    Our products and services are used by a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.

    a collaborative approach
    In concert with prospective customers and partners, Illumina takes a highly collaborative approach to business relationships. We're good listeners, value feedback, and believe in working together. Illumina is committed to providing our customers with world-class solutions, service, and support throughout their relationship with us to maximize their scientific success.

    Building the illumina community
    Staffed with a cohesive mix of high-performing scientists, engineers, managers, and support staff, Illumina is committed to building a team that delivers high-quality products and industry-leading service to the marketplace. Every employee is a critical part of the growing Illumina Community. Through our actions we strive to invite everyone associated with our company to become a part of this community. This includes customers, collaborators, suppliers, and industry colleagues.

    Key Management:
    Jay T. Flatley
    President & Chief Executive Officer

    Christian G. Cabou
    Senior Vice President & General Counsel

    Gregory F. Heath, Ph.D.
    Senior Vice President & General Manager, Diagnostics Business Unit

    Christian Henry
    Senior Vice President, Chief Financial Officer & General Manager, Life Sciences Business Unit

    Tristan B. Orpin
    Senior Vice President & Chief Commercial Officer

    Nicholas J. Naclerio, Ph.D.
    Senior Vice President, Corporate Development

    Mostafa Ronaghi, Ph.D.
    Senior Vice President & Chief Technology Officer

     Key Statistics


    Email: info@illumina.com
    Ownership: Public

    Web Site: Illumina
    Employees: 1200+
    Symbol: ILMN
     









  •  Company News
    Hudson-Alpha Institute for Biotechnology Announces Purchase Of Illumina (ILMN) Hiseq X Ten Sequencing System 12/15/2014 7:27:29 AM
    Illumina (ILMN) And Sequenom Inc. (SQNM) Pool Noninvasive Prenatal Testing Intellectual Property And End Outstanding Patent Disputes 12/3/2014 9:07:11 AM
    Illumina (ILMN) Moving Forward With San Diego Expansion, 300 New Jobs 12/2/2014 1:33:03 PM
    U.S. Agency for International Development, Broad Institute, And Illumina, Inc. (ILMN) Form A Public-Private Partnership Combating The Ebola Epidemic In West Africa 11/19/2014 11:47:35 AM
    bioMérieux And Illumina, Inc. (ILMN) Enter Agreement To Co-Develop A Next-Generation Sequencing Solution For Epidemiological Monitoring Of Bacterial Infections 11/18/2014 10:43:26 AM
    Sequenta, Inc. Enters Agreement With Illumina, Inc. (ILMN) On In Vitro Diagnostic Kit For Sequencing-Based Minimal Residual Disease Testing 11/17/2014 7:12:52 AM
    Tute Genomics Now Available In Illumina, Inc. (ILMN)'s BaseSpace Apps 11/5/2014 7:57:01 AM
    HTG Announces Completion Of IVD Development And Supply Agreement With Illumina, Inc. (ILMN) 10/30/2014 9:17:14 AM
    PEDANT™ Application For Convenient, Comprehensive Genomic Analysis Now Available In Illumina, Inc. (ILMN)’s Basespace Apps 10/28/2014 10:07:42 AM
    Illumina, Inc. (ILMN) Reports Record Financial Results For Third Quarter Of Fiscal Year 2014 10/21/2014 9:42:47 AM
    12345678910...